about
Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible IsolatesEpidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in ShanghaiGenerational distribution of a Candida glabrata population: Resilient old cells prevail, while younger cells dominate in the vulnerable hostAmino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance.Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year periodRecent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsThe epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study.Distribution of yeast-like fungi at a university hospital in TurkeyHow much European prescribing physicians know about invasive fungal infections management?Antibiotic exposure as a risk factor for fluconazole-resistant Candida bloodstream infectionImpact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia.Species identification of invasive yeasts including Candida in Pakistan: limitations of phenotypic methods.Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational studyClinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species.Pharmacokinetic evaluation of fluconazole in critically ill patients.Candida krusei: biotechnological potentials and concerns about its safety.Current pharmacological concepts for wise use of echinocandins in the treatment of Candida infections in septic critically ill patients.A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.Antifungal drug resistance among Candida species: mechanisms and clinical impact.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.The Correlation Between Biofilm Production and Catheter-Related Bloodstream Infections Sustained by Candida. A Case Control Study.Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches.Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study.Factors Influencing Non-albicans Candidemia: A Case-Case-Control Study.T2 Magnetic Resonance for Fungal Diagnosis.The Changing Epidemiology of Invasive Fungal Infections.Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.Antifungal resistance does not necessarily affect Candida glabrata fitness.Evaluation of Candida species and antifungal susceptibilities among children with invasive candidiasis.Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.Viable quantitative PCR for assessing the response of Candida albicans to antifungal treatment.Distribution and antifungal susceptibility of yeasts isolates from intensive care unit patients.Exogenous tyrosol inhibits planktonic cells and biofilms of Candida species and enhances their susceptibility to antifungals.Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
P2860
Q28833536-2AA8173F-E9E2-4B61-90F7-AFFBDB05143CQ33661367-D4702039-8074-4A35-985C-B10776DE022AQ33714031-5BAEDEED-AFE6-4386-99D3-90D4736C40A8Q33940714-B742E1AE-AE8F-48A6-B203-5E875080A4CFQ34252030-26472884-BE5C-4910-B0FF-3E981C0859B7Q34529026-0106AADA-DC60-415B-A9D3-D2B4FBA75D74Q34586566-5104A7C6-3EE7-41EB-BB93-1AE0CED9EFCDQ35105024-33F8827E-B26D-4AEF-B54B-F2C2F4E614E5Q35131938-47EF1327-2EE2-4D56-9D90-6D9D0F7B7439Q35941512-BC515A06-8A06-47C3-A834-27C1E3A00B1BQ36018860-EF8E3C5D-4CD2-4343-8CE5-5421174ED672Q36219123-4CC96878-1656-4B68-88D8-9D7D8C883176Q36423773-33E6F458-6E7D-48BD-8F73-97DF13690413Q36584767-3EA28FA7-96F5-4266-8576-B2071B3A49C8Q37480190-84F9B0E9-0EA0-44ED-A3CA-7990C4B8D9A3Q37924819-70ADA23F-89F2-46E4-87DE-74F624641507Q38028552-4B139DE8-CFB4-4027-85D1-8AB6B8A07E86Q38149163-76BEAA26-98FC-4510-8C12-5D471248637EQ38150728-985B4DD4-7D2F-40BD-A507-01BEEF4564FDQ38511946-2631422C-2126-4833-9147-ADED431E1D68Q38711698-6B6A191E-02C3-4506-A0EB-5B077AF445E1Q38954405-AD1D21CB-44EC-41C6-A7E0-6A2EC5CB4B15Q39062989-BB433B9D-D611-474E-A899-07E5A4DFB414Q40169961-562AD067-B26D-4F54-8E2E-160BC2C07EF0Q40205203-DA2D50E0-071F-4C23-87B4-64C7BD647A8CQ40454814-DCA475AB-2AF9-4127-A14E-E0A4D09269A3Q40454886-640D8BD9-8713-4B13-AAE6-7DAEDDBBF27AQ40748882-BB279799-EFC7-4D20-967B-20ED435A78F0Q41546170-F89D5C1D-91FC-4E4E-9C7C-9E09FED67925Q42006463-49E91ABB-CF40-4F9A-95E8-C8A66DC7AB58Q43064003-906DC464-4B95-4CBA-8241-FF597530D739Q43427231-288C5C62-A02A-466A-B5BE-0605D647FC95Q43811410-A8542617-0371-49BB-A9F5-BB2011294AADQ44854926-06197606-9009-48FB-B4BB-BA0E0E9BA4EAQ46393306-F6EB4549-4433-43EF-849F-B21D6D6038BBQ46755845-9D342ED4-C004-4016-86D3-F005CAB3CDA2Q46876396-F0308436-4BEF-41EB-ADD5-E628C387D33A
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Risk factors for fluconazole-resistant candidemia.
@en
Risk factors for fluconazole-resistant candidemia.
@nl
type
label
Risk factors for fluconazole-resistant candidemia.
@en
Risk factors for fluconazole-resistant candidemia.
@nl
prefLabel
Risk factors for fluconazole-resistant candidemia.
@en
Risk factors for fluconazole-resistant candidemia.
@nl
P2093
P2860
P50
P356
P1476
Risk factors for fluconazole-resistant candidemia.
@en
P2093
Ana Díaz-Martín
Carlos Ortiz-Leyba
Clara Hernández-Caballero
José M Cisneros
Maite Ruiz Pérez de Pipaón
P2860
P304
P356
10.1128/AAC.00479-10
P407
P577
2010-05-24T00:00:00Z